Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maura Dandri

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
The Lancet. Neurology|October 8, 2020
Neuropathology of patients with COVID-19 in Germany: a post-mortem case seriesJakob Matschke, Marc Lütgehetmann, Christian Hagel, et al.
JHEP Reports : Innovation in Hepatology|February 21, 2025
Hepatitis D virus infection triggers CXCL9-11 upregulation in hepatocytes and liver infiltration of CXCR3+ CD4 T cellsJan-Hendrik Bockmann, Lena Allweiss, Annika Volmari, et al.
The Lancet. Gastroenterology & Hepatology|April 15, 2019
A global scientific strategy to cure hepatitis BPeter A Revill, Francis V Chisari, Joan M Block, et al.
Scientific Reports|September 17, 2025
Prevalence and risk factors of viral hepatitis and HIV among people experiencing homelessness in Germany based on a nationwide studyFabian Heinrich, Tsz Lun Ernest Wong, Wiebke Graf, et al.
Scientific Reports|May 19, 2026
Spatiotemporal distribution of SARS-CoV-2 vaccines and vaccine-related proteins in mice and humansFabian Heinrich, Jöran Lücke, Siwen Zhang, et al.
Plos Computational Biology|January 9, 2025
Prediction of cccDNA dynamics in hepatitis B patients by a combination of serum surrogate markersKwang Su Kim, Masashi Iwamoto, Kosaku Kitagawa, et al.
Journal of Hepatology|October 29, 2017
A novel orally available small molecule that inhibits hepatitis B virus expressionHenrik Mueller, Steffen Wildum, Souphalone Luangsay, et al.
Science (New York, N.Y.)|February 22, 2014
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNAJulie Lucifora, Yuchen Xia, Florian Reisinger, et al.
Nature Communications|February 26, 2025
Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric miceGeorge Ssebyatika, Katja Dinkelborg, Luisa J Ströh, et al.
The Lancet. Infectious Diseases|September 16, 2022
Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trialHeiner Wedemeyer, Katrin Schöneweis, Pavel Bogomolov, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
The Lancet. Neurology|October 8, 2020
Neuropathology of patients with COVID-19 in Germany: a post-mortem case seriesJakob Matschke, Marc Lütgehetmann, Christian Hagel, et al.
JHEP Reports : Innovation in Hepatology|February 21, 2025
Hepatitis D virus infection triggers CXCL9-11 upregulation in hepatocytes and liver infiltration of CXCR3+ CD4 T cellsJan-Hendrik Bockmann, Lena Allweiss, Annika Volmari, et al.
The Lancet. Gastroenterology & Hepatology|April 15, 2019
A global scientific strategy to cure hepatitis BPeter A Revill, Francis V Chisari, Joan M Block, et al.
Scientific Reports|September 17, 2025
Prevalence and risk factors of viral hepatitis and HIV among people experiencing homelessness in Germany based on a nationwide studyFabian Heinrich, Tsz Lun Ernest Wong, Wiebke Graf, et al.
Scientific Reports|May 19, 2026
Spatiotemporal distribution of SARS-CoV-2 vaccines and vaccine-related proteins in mice and humansFabian Heinrich, Jöran Lücke, Siwen Zhang, et al.
Plos Computational Biology|January 9, 2025
Prediction of cccDNA dynamics in hepatitis B patients by a combination of serum surrogate markersKwang Su Kim, Masashi Iwamoto, Kosaku Kitagawa, et al.
Journal of Hepatology|October 29, 2017
A novel orally available small molecule that inhibits hepatitis B virus expressionHenrik Mueller, Steffen Wildum, Souphalone Luangsay, et al.
Science (New York, N.Y.)|February 22, 2014
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNAJulie Lucifora, Yuchen Xia, Florian Reisinger, et al.
Nature Communications|February 26, 2025
Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric miceGeorge Ssebyatika, Katja Dinkelborg, Luisa J Ströh, et al.
The Lancet. Infectious Diseases|September 16, 2022
Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trialHeiner Wedemeyer, Katrin Schöneweis, Pavel Bogomolov, et al.
Pageof 11